BCPC Quote, Financials, Valuation and Earnings

Innospec has a net margin of 14.1% compared to Balchem's net margin of 7.53%. Balchem's return on equity of 11.16% beat Innospec's return on equity of 12.17%.

Balchem has a consensus price target of $190.33, signalling upside risk potential of 18.58%. On the other hand Innospec has an analysts' consensus of -- which suggests that it could grow by 16.03%. Given that Balchem has higher upside potential than Innospec, analysts believe Balchem is more attractive than Innospec.

Balchem has a beta of 0.686, which suggesting that the stock is 31.375% less volatile than S&P 500. In comparison Innospec has a beta of 1.093, suggesting its more volatile than the S&P 500 by 9.261%.

Balchem has a quarterly dividend of $0.87 per share corresponding to a yield of 0.54%. Innospec offers a yield of 1.37% to investors and pays a quarterly dividend of $0.79 per share. Balchem pays 21.07% of its earnings as a dividend. Innospec pays out 25.23% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Balchem quarterly revenues are $239.9M, which are smaller than Innospec quarterly revenues of $443.4M. Balchem's net income of $33.8M is higher than Innospec's net income of $33.4M. Notably, Balchem's price-to-earnings ratio is 43.15x while Innospec's PE ratio is 19.70x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Balchem is 5.56x versus 1.51x for Innospec. Usually stocks with elevated PS ratios are considered overvalued.

The Mosaic has a net margin of 14.1% compared to Balchem's net margin of 4.35%. Balchem's return on equity of 11.16% beat The Mosaic's return on equity of 3.06%.

Balchem has a consensus price target of $190.33, signalling upside risk potential of 18.58%. On the other hand The Mosaic has an analysts' consensus of $32.30 which suggests that it could grow by 20.87%. Given that The Mosaic has higher upside potential than Balchem, analysts believe The Mosaic is more attractive than Balchem.

Balchem has a beta of 0.686, which suggesting that the stock is 31.375% less volatile than S&P 500. In comparison The Mosaic has a beta of 1.338, suggesting its more volatile than the S&P 500 by 33.838%.

Balchem has a quarterly dividend of $0.87 per share corresponding to a yield of 0.54%. The Mosaic offers a yield of 3.14% to investors and pays a quarterly dividend of $0.21 per share. Balchem pays 21.07% of its earnings as a dividend. The Mosaic pays out 30.18% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Balchem quarterly revenues are $239.9M, which are smaller than The Mosaic quarterly revenues of $2.8B. Balchem's net income of $33.8M is lower than The Mosaic's net income of $122.2M. Notably, Balchem's price-to-earnings ratio is 43.15x while The Mosaic's PE ratio is 23.65x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Balchem is 5.56x versus 0.75x for The Mosaic. Usually stocks with elevated PS ratios are considered overvalued.

Paramount Gold Nevada has a net margin of 14.1% compared to Balchem's net margin of --. Balchem's return on equity of 11.16% beat Paramount Gold Nevada's return on equity of --.

Balchem has a consensus price target of $190.33, signalling upside risk potential of 18.58%. On the other hand Paramount Gold Nevada has an analysts' consensus of -- which suggests that it could grow by 233.33%. Given that Paramount Gold Nevada has higher upside potential than Balchem, analysts believe Paramount Gold Nevada is more attractive than Balchem.

Balchem has a beta of 0.686, which suggesting that the stock is 31.375% less volatile than S&P 500. In comparison Paramount Gold Nevada has a beta of 1.881, suggesting its more volatile than the S&P 500 by 88.144%.

Balchem has a quarterly dividend of $0.87 per share corresponding to a yield of 0.54%. Paramount Gold Nevada offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Balchem pays 21.07% of its earnings as a dividend. Paramount Gold Nevada pays out -- of its earnings as a dividend. Balchem's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Balchem quarterly revenues are $239.9M, which are larger than Paramount Gold Nevada quarterly revenues of --. Balchem's net income of $33.8M is higher than Paramount Gold Nevada's net income of -$1.6M. Notably, Balchem's price-to-earnings ratio is 43.15x while Paramount Gold Nevada's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Balchem is 5.56x versus -- for Paramount Gold Nevada. Usually stocks with elevated PS ratios are considered overvalued.

Solitario Resources has a net margin of 14.1% compared to Balchem's net margin of --. Balchem's return on equity of 11.16% beat Solitario Resources's return on equity of --.

Balchem has a consensus price target of $190.33, signalling upside risk potential of 18.58%. On the other hand Solitario Resources has an analysts' consensus of $1.50 which suggests that it could grow by 130.77%. Given that Solitario Resources has higher upside potential than Balchem, analysts believe Solitario Resources is more attractive than Balchem.

Balchem has a beta of 0.686, which suggesting that the stock is 31.375% less volatile than S&P 500. In comparison Solitario Resources has a beta of 0.890, suggesting its less volatile than the S&P 500 by 10.984%.

Balchem has a quarterly dividend of $0.87 per share corresponding to a yield of 0.54%. Solitario Resources offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Balchem pays 21.07% of its earnings as a dividend. Solitario Resources pays out -- of its earnings as a dividend. Balchem's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Balchem quarterly revenues are $239.9M, which are larger than Solitario Resources quarterly revenues of --. Balchem's net income of $33.8M is higher than Solitario Resources's net income of -$2.3M. Notably, Balchem's price-to-earnings ratio is 43.15x while Solitario Resources's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Balchem is 5.56x versus -- for Solitario Resources. Usually stocks with elevated PS ratios are considered overvalued.